23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
1.300
+0.030 (2.36%)
Apr 23, 2025, 4:00 PM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $34.07 million as of April 23, 2025. Its market cap has decreased by -85.15% in one year.
Market Cap
34.07M
Enterprise Value
15.26M
Revenue
208.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.30
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 34.07M, a decrease of -94.53%. That is a compound annual growth rate of -48.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 34.87M | -58.47% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.69B |
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Northwest Biotherapeutics | 489.55M |
| Elite Pharmaceuticals | 449.74M |
| Glass House Brands | 419.36M |
| CytoDyn | 279.15M |